07/23/2026
Hoping to build pharmaceutical production in the U.S. is complex and costly — and nearly all the inputs would still come from abroad. The potential 200% tariff will not change the fundamental math. These changes will take effect in 2028 and the price of many generic drugs will triple in cost.
The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.